Can you verify the current step therapy protocols required by Aetna before approving PCSK9 inhibitors for high-risk cardiac patients?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
Can you verify the current step therapy protocols required by Aetna before approving PCSK9 inhibitors for high-risk cardiac patients?
2 real searches · 1 real-search pass
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
ChatGPT real searches (2)
Classes come from the query-classifier (a local Laya model). 1 of 2 calls are low-confidence (under 50%) — hover a query in the table to see its confidence.
Searches and sources
Queries
2 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
Aetna 2026 PCSK9 inhibitor prior authorization step therapy criteria Repatha Praluent official policy OBSERVED | Google ↗ AI Mode ↗ | — | Consequence | — | — | 1x of 1 | |
site:aetna.com/cpb PCSK9 inhibitors evolocumab alirocumab coverage policy LDL step therapy OBSERVED | Google ↗ AI Mode ↗ | — | Other / navigational | — | — | 1x of 1 |